Pathology Software Algorithm Device Analyzing Digital Images For Prostate Cancer Prognosis
SFH is the FDA product code for Pathology Software Algorithm Device Analyzing Digital Images For Cancer Prognosis, a class II device type, regulated under 21 CFR 864.3755. FDA's definition for this code reads: "A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from prostate biopsies prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic...". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- SFH
- Device name
- Pathology Software Algorithm Device Analyzing Digital Images For Prostate Cancer Prognosis
- FDA definition
- A pathology software algorithm device analyzing digital images for prostate cancer prognosis is a software intended to analyze digital images of acquired from medical imaging devices (for example but not limited to - whole slide imaging scanners). The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.
- Regulation
- 21 CFR 864.3755
- Device class
- Class II
- Review panel
- Pathology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code SFH
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2025 | 1 |
Applicants with the most clearances
Product code SFH| Applicant | Clearances |
|---|---|
| Artera | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
